Betta Pharmaceuticals Co., Ltd. (300558.SZ)
300558.SZ
Loading signal…
Key stats
- Market cap
- $19.1B
Industry peers
FMP comparable companies · ranked by market cap
- 600276.SSJiangsu Hengrui Medicine Co., Ltd.$290.3B$45.51
- 688235.SSBeOne Medicines Ltd. Class A$255.2B$244.00
- 688331.SSRemeGen Co. Ltd. Class A$58.0B$104.75
- 688266.SSSuzhou Zelgen Biopharmaceuticals Co., Ltd.$26.2B$99.00
- 688176.SSJiangsu Yahong Meditech Co Ltd$7.4B$12.95
- 688091.SSShanghai Yizhong Pharmaceutical Co., Ltd.$7.4B$35.78
- 688553.SSSichuan Huiyu Pharmaceutical Co., Ltd.$7.1B$11.32
- 000518.SZJiangsu Sihuan Bioengineering Co., Ltd$3.7B$3.57
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FAQ
- What is LOPJLB’s current signal on 300558.SZ?
- LOPJLB publishes daily direction and regime signals for 300558.SZ on this page.
- What market regime is 300558.SZ in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Betta Pharmaceuticals Co., Ltd. (300558.SZ) do?
- Betta Pharmaceuticals Co., Ltd. is a Chinese pharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of oncology treatments. Among its key offerings are Icotinib hydrochloride, an orally taken epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, and Ensartinib hydrochloride, an anaplastic lymphoma kinase (ALK) inhibitor, both utilized i…